Author: Ruchi

Zeal Therapeutics, our lab startup, has been covered in media for our recent Molecular Therapy publication, “Efficient and Selective Kidney Targeting by Chemically Modified Carbohydrate Conjugates,” highlighting the innovative approaches behind our research.

Posted on by

Our recently published work in Molecular Therapy has been covered media news outlet.

Please check these out:

School of Pharmacy Startup Develops Promising Kidney-Targeting Drug Delivery System – UConn Today